FRENCKEN GROUP LIMITED (SGX:E28)
Frencken Group - Resilience & Diversity; Proxy To Growth Trends In 5G/AI
BUY Frencken for margin expansion potential
- We see Frencken Group (SGX:E28) as a proxy to growth trends in 5G/AI, health and wellness and population ageing through its blue-chip customers.
- In the short term, semiconductor equipment/analytical/automotive end-markets, which form around 70% of sales, should provide cyclical resilience. Longer-term, we are excited by margin growth potential from deepening value-add with customers as Frencken launches a breadth of products in coming years.
- Maintain BUY on Frencken with ROE-g/COE-g target price of S$1.39 (1.6x FY21E P/B).
Deepening engagement with blue chip customers
- In its mechatronics segment (c.80% of revenues), Frencken’s market-leading customers include ASML, Seagate, Thermo Fisher and Philips. Mechatronics products tend to be critical, have demanding requirements, and Frencken is usually the sole source.
- Frencken is currently involved in a breadth of new products across semiconductor, analytical, medical and others slated for launch in coming years. As it provides greater design value-add, we believe margin expansion potential is currently underappreciated.
Around 70% of revenue in upswing/ recovery
- We forecast earnings growth of 21% for Frencken in FY21E – which we see underpinned by semiconductor equipment, analytical, and automotive end-markets, which we estimate account for around 70% of Frencken's revenues. These segments are currently in various degrees of upswing/recovery.
- Frencken's balance sheet is clean with net cash to equity of around 8%.
- See Frencken Group Share Price; Frencken Group Target Price; Frencken Group Analyst Reports; Frencken Group Dividend History; Frencken Group Announcements; Frencken Group Latest News.
Risks
Gene Lih Lai CFA
Maybank Kim Eng Research
|
https://www.maybank-ke.com.sg/
2020-11-21
SGX Stock
Analyst Report
1.390
SAME
1.390